Phorbol 12-myristate 13-acetate (PMA) inhibited the stimulation of ureogenesis produced by adrenaline, but produced a minimal displacement to the right of the dose-response curve for glucagon. However, PMA diminished the accumulation of cyclic AMP induced by glucagon. Dissociation between the cyclic AMP concentrations and the metabolic effects induced by glucagon is evidenced in the presence of phorbol esters.
Phorbol 12-myristate 13-acetate (PMA) inhibited the stimulation of ureogenesis produced by adrenaline, but produced a minimal displacement to the right of the dose-response curve for glucagon. However, PMA diminished the accumulation of cyclic AMP induced by glucagon. Dissociation between the cyclic AMP concentrations and the metabolic effects induced by glucagon is evidenced in the presence of phorbol esters.
Phorbol esters are a series of mitogenic compounds which induce phenotypic changes in mammalian cells resembling those produced by oncogenic viruses. The mechanism of action of these tumour promoters is not completely known. However, some evidence indicates that phorbol esters bind and stimulate a Ca2+-activated phospholipid-dependent kinase, known as protein kinase C (Castagna et al., 1982; Kikkawa et al., 1983) . Activation of this kinase seems to be the major route whereby these tumour promoters exert their actions.
It has been shown that activation of protein kinase C by phorbol diesters can alter the cellular responsiveness to a variety of agents; this change in responsiveness seems to be associated with changes in the number, state of affinity or state of phosphorylation of the receptors (Shoyab et al., 1979; Grumberger & Gordon, 1982; Cochet et al., 1984; Corvera & Garcia-Sainz, 1984; Davies & Czech, 1984; Heyworth et al., 1984; Iwasita & Fox, 1984; May et al., 1984; Moon et al., 1984) . We have previously shown that in isolated hepatocytes PMA completely blocks al -adrenergic stimulation of glycogenolysis (Corvera & Garcia-Sainz, 1984) . This effect of phorbol esters seems to be quite specific for ax,-adrenergic actions, since we observed that the stimulations of glycogenolysis by other agents such as vasopressin, angiotensin, ionophore A23187 and glucagon were not affected by these agents (Corvera & Garcia-Sainz, 1984) . However, Heyworth et al. (1984) (Gutman & Bergmeyer, 1974 Gilman (1970) . Free cyclic AMP was separated from bound cyclic AMP by charcoal adsorption as described by Brown et al. (1971) .
Results
Adrenaline produced a dose-dependent stimulation of ureogenesis (Fig. 1) . This effect is mediated through stimulation of a, -adrenoceptors (Corvera & Garcia-Sa'inz, 1981) . Confirming our previous results on glycogenolysis (Corvera & Garcia-Salinz, 1984) , it was observed that 0.1 uM-PMA blocked this effect of adrenaline (Fig. 1) . In contrast, the dose-response curve for glucagon was only minimally shifted to the right by 0.1-1 pM-PMA (Fig.   2) Glucagon produced a dose-dependent increase in cyclic AMP accumulation (Fig. 3) , which was significantly decreased by PMA (Fig. 3) . This phorbol ester, at 0.1 and 1 RM, clearly shifted the dose-response curve for glucagon to the right, decreased the maximal effect and diminished the steepness of the curve (Fig. 3) , indicating clearly a non-competitive type of inhibition. PMA alone was without effect at the concentrations tested.
To characterize this effect further, a fixed concentration of glucagon was antagonized by different concentrations of phorbol derivatives (Fig. 4) . PMA produced a dose-dependent inhibition of the effect of glucagon, reaching a maximal inhibition of approx. 50% at 1 ,UM (Fig. 4) . PDA also produced a dose-dependent inhibition of similar magnitude, but it was about 1 order of magnitude less potent than PMA (Fig. 4) . In contrast, 4fl-phorbol was completely inactive (Fig.   4 ).
Discussion
The ability of phorbol esters to inhibit glucagonmediated cyclic AMP accumulation (Heyworth et al., 1984) (Fig. 3) , a minimal shift in the dose-response curve for the effect of glucagon on ureogenesis was observed (Fig. 2) . This is essentially consistent with our previous findings in which another metabolic parameter, glycogenolysis, was studied (Corvera & GarciaSainz, 1984) . In other words, in the presence of phorbol esters, a clear dissociation between glucagon-mediated cyclic AMP accumulation and glucagon-mediated metabolic effects is observed. We (Cairdenas-Tanu(s et al., 1982; and other authors (Okajima & Ui, 1976; Birnbaum & Fain, 1977; Fain & Shepherd, 1977; Khan et al., 1980) (Fig. 1) , whereas the same concentration of PMA only partially decreases glucagon-mediated cyclic AMP accumulation (Figs. 3 and 4 ). It is difficult to interpret this difference at present. Both effects seem to be mediated through activation of protein kinase C. This is based on the potency order of the phorbol derivatives [PMA > PDA > > > phorbol (Fig. 4 , and Corvera & Garcia-Sainz, 1984)], which is identical with that observed for binding and activation of protein kinase C (Castagna et al., 1982; Kikkawa et al., 1983) . Furthermore, Heyworth et al. (1984) have shown that Ca2+ and phosphatidylserine, which are cofactors of protein kinase C (Castagna et al., 1982) , are required to reproduce the effect of PMA on adenylate cyclase in purified plasma membranes.
Heyworth et al. (1984) have suggested that the action of phorbol ester may be exerted at the point of regulation of adenylate cyclase by guanine nucleotides. On the other hand, we (Corvera & Garcia-Sa'inz, 1984) have suggested that the action of phorbol esters on a,-adrenergic-mediated effects probably occurs at the receptor level. Neither of these suggestions has been definitively demonstrated yet. However, the findings are consistent with the idea that activation of protein kinase C by phorbol esters alters the cell responsiveness by inducing significant changes in the metabolic dynamic of the plasma membrane.
